Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 265-996-3 | CAS number: 65996-65-8 The product of agglomerating iron ore fines, concentrates, iron sinter, and other iron-bearing materials. Includes pellets, nodules and briquettes.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
- Systemic exposure to iron oxides after oral administration is not expected to reach toxicologically significant levels. The physicochemical properties of the substances prevent the necessary dissolution of the oxides themselves or the conversion to iron ions or iron chelates in the gastrointestinal tract.
- After inhalation of iron oxide particles, the mechanism of pulmonary clearance is activated and the material is removed directly and/or after phagocytosis by the macrophages, via mucociliary transport to the pharyngeal region. Part of this cleared material will subsequently be ingested and eliminated via the faeces. Systemic exposure after inhalation is deemed negligible, since no absorption in the gastrointestinal tract of the insoluble oxides is expected.
- The iron oxide particles covered by the present dossier are too large to be translocated directly from the alveoli via the epithelium to extrapulmonary organs, a systemic exposure postulated for nanoparticles (MMAD <100 nm).
- Systemic exposure after intracellular break down of the oxide by the lysosomal system of the macrophages will be negligible, due to the very slow rate of this process. This rate diminishes further when larger particles are ingested.
- The secondary oral exposure to iron oxides for workers after inhalation at the 3 mg/m3 threshold for respirable inert dust and the 10 mg/m3 threshold for inhalable inert dust will not lead to any substantial systemic exposure, due to the physicochemical properties of iron oxides.
See attached document and the read-across statement attached to summary Toxicological information. The conclusions listed in the first document are reproduced below.
Conclusions
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.